| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 62893-20-3 | 頭孢哌酮鈉; 7-[[(4-乙基-2,3-二氧代-1-哌嗪基)甲酰氨基](4-羥基苯基)乙酰氨基]-3-[(1-甲基-1H-四唑-5-基)硫 | Cefoperazone sodium; [6R-[6alpha,7beta(R*)]]-7-[[[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-car |  | C25H26N9NaO8S2 | 詳情 | 供應(yīng)商 |
| 132019-54-6 | 莫那匹爾; N-(6,11-二氫苯并[c][1]苯并硫雜卓-11-基)-4-[4-(4-氟苯基)哌嗪-1-基]丁酰胺 | Monatepil; N-(6,11-Dihydrobenzo[c][1]benzothiepin-11-yl)-4-[4-(4-fluorophenyl)piperazin-1-yl]butanamide |  | C28H30FN3OS | 詳情 | 供應(yīng)商 |
| 639089-54-6 | 陶扎色替; N-[4-[[4-(4-甲基-1-哌嗪基)-6-[(5-甲基-1H-吡唑-3-基)氨基]-2-嘧啶基]硫]苯基]環(huán)丙烷甲酰胺 | Tozasertib; N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide; MK 0457; VX 680 |  | C23H28N8OS | 詳情 | 供應(yīng)商 |
| 439574-61-5 | N-(5-((5-(4-乙酰基哌嗪-1-甲�；�)-4-甲氧基-2-甲基苯基)硫基)噻唑-2-基)-4-(((3-甲基丁烷-2-基)氨基)甲基) | N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3-methylbu | 無 | C31H39N5O4S2 | 詳情 | 供應(yīng)商 |
| 960203-27-4 | 1-[2-[(2,4-二甲基苯基)硫基]苯基]哌嗪氫溴酸鹽; 1-[2-[(2,4-二甲基苯基)硫基]苯基]哌嗪氫溴酸鹽; 沃替西汀氫溴酸鹽 | Vortioxetine hydrobromide; 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine hydrobromide; Lu AA 21004 hydrobromide; Vortioxetine hydrobromide; Lu AA21004 (HBr) | 無 | C18H22N2S.HBr | 詳情 | 供應(yīng)商 |
| 439575-02-7 | N-(5-((5-(4-乙�；�哌嗪-1-甲�；�)-4-甲氧基-2-甲基苯基)硫基)噻唑-2-基)-4-(((3,3-二甲基丁烷-2-基)氨基)甲基)苯甲酰胺; N-(5-((5-(4-乙酰基哌嗪-1-甲�；�)-4-甲氧基-2-甲基苯基)硫基)噻唑-2-基)-4-(((3,3-二甲基丁烷-2-基)氨基)甲基)苯甲酰胺 | N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide; BMS 509744; N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide |  | C32H41N5O4S2 | 詳情 | 供應(yīng)商 |